Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01661 |
| Species: | Homo sapiens |
| Position : | chr20:54119731-54198946 |
| Year: | 2024 |
| Title: | MYC activity at enhancers drives prognostic transcriptional programs through an epigenetic switch |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast carcinoma |
| PMID: | 38454021 |
| MONDO: | MONDO:0006120 |
| Tissue: | Breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | MCF7 (ER+) |
| CVCL ID: | CVCL_0031 |
| Cell Type: | breast carcinoma cell |
| Cell Ontology ID: | CL:0000646 |
| Experiment Type: | TF binding assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | Fulvestrant treatment, RT-RT-qPCR |
| Target gene : | CYP24A1 |
| TF name : | MYC; ESR1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|